Premium
Line, Please
Author(s) -
Alan Meisel,
Antal E. Solyom,
Nikola BillerAndorno,
Eliane Pfister,
Jean Martin,
James S. Boal
Publication year - 2009
Publication title -
hastings center report
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.515
H-Index - 63
eISSN - 1552-146X
pISSN - 0093-0334
DOI - 10.1353/hcr.0.0126
Subject(s) - principle of legality , resistance (ecology) , law , morality , assisted suicide , history , medicine , psychoanalysis , philosophy , political science , psychology , ecology , biology
March-April 2009 To the Editor: From the moment that contemporary medicine began to acquire the ability to stave off death almost indefinitely, the question arose as to whether there could be too much of a good thing. This question is debated to this day, as is evidenced by the essay set featured in the September-October 2008 issue of the Hastings Center Report. Just three decades ago, the morality, legality, and practicality of knowing when to resign ourselves to the inevitability of death began to be openly debated. Over the ensuing years, a consensus about forgoing life-sustaining treatment gradually emerged and became reasonably well accepted, though resistance to it continues and probably will for a long time to come. The consensus has taken root only because of the insistence that there is a bright line between “passive” means of hastening death and “active” means— that is, between withholding and withdrawing medical treatment on the one hand, and active euthanasia and assisting suicide on the other. To have failed to draw this line would have meant either accepting all means of hastening death or none, and it is highly unlikely that the former could have prevailed; that would have meant keeping everyone alive until they died even with the administration of maximal life-sustaining medical treatment. The line never was as bright as its proponents claimed—hence the accuracy of Margaret Battin’s calling it a “false bright line” in her essay (“Terminal Sedation: Pulling the Sheet over Our Eyes”)—but practical and political purposes made insisting that it was a bright line necessary. For if we had acknowledged how blurry the line really is, it is unlikely that a consensus about forgoing life-sustaining treatment could have been hammered out at all. Unfortunately, the consensus about forgoing life-sustaining medical treatment is not a panacea that resolves all end-of-life dilemmas. For some, merely stopping medical miracles cannot provide relief from pain, from suffering, from loss of control. Is there a more eloquent penned example than Susan Wolf provides us about her father’s death (“Confronting Physician-Assisted Suicide and Euthanasia: My Father’s Death”)? Hospice—and, for that matter, palliative care in all its manifestations—has provided much, if not most, of that needed relief. But not all.